JPMORGAN CHASE & CO - SYROS PHARMACEUTICALS INC ownership

SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 3 filers reported holding SYROS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of SYROS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$3,000
-92.7%
2,908
-91.6%
0.00%
Q1 2022$41,000
-54.9%
34,537
+24.4%
0.00%
Q4 2021$91,000
-24.2%
27,768
+4.2%
0.00%
Q3 2021$120,000
-88.0%
26,658
-85.5%
0.00%
Q2 2021$1,000,000
-79.9%
183,553
-72.4%
0.00%
-100.0%
Q1 2021$4,966,000
-37.8%
663,905
-9.8%
0.00%0.0%
Q4 2020$7,984,000
+14.0%
735,872
+0.4%
0.00%0.0%
Q3 2020$7,005,000
-17.1%
732,726
-7.6%
0.00%
-50.0%
Q2 2020$8,455,000
+61.8%
793,254
-10.0%
0.00%
+100.0%
Q1 2020$5,227,000
-20.1%
881,537
-6.8%
0.00%0.0%
Q4 2019$6,538,000
+49.7%
946,092
+124.9%
0.00%0.0%
Q3 2019$4,366,000
+34.7%
420,586
+3.1%
0.00%0.0%
Q2 2019$3,242,000
-11.6%
407,843
+1.7%
0.00%0.0%
Q1 2019$3,666,000
+63.9%
401,072
-0.2%
0.00%0.0%
Q4 2018$2,237,000
-49.2%
401,762
+8.6%
0.00%0.0%
Q3 2018$4,406,000
+19.3%
369,959
+2.3%
0.00%0.0%
Q2 2018$3,693,000
-24.0%
361,673
-3.4%
0.00%0.0%
Q1 2018$4,861,000
+52.0%
374,513
+13.9%
0.00%0.0%
Q4 2017$3,199,000
+66.1%
328,798
+159.9%
0.00%
Q3 2017$1,926,000
+9.6%
126,530
+15.9%
0.00%
Q2 2017$1,757,000
-8.5%
109,200
-9.4%
0.00%
Q1 2017$1,921,000
+22.4%
120,556
-6.6%
0.00%
Q4 2016$1,570,000
-17.0%
129,118
-5.3%
0.00%
Q3 2016$1,892,000136,4070.00%
Other shareholders
SYROS PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 4,806,656$58,449,00019.02%
Casdin Capital, LLC 182,141$2,215,0001.83%
Aisling Capital LLC 508,565$6,184,0001.44%
Redmile Group, LLC 948,440$11,533,0000.99%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,812,778$22,043,0000.91%
EcoR1 Capital, LLC 63,596$773,0000.25%
Eventide Asset Management 150,000$1,824,0000.12%
AWM Investment Company, Inc. 47,550$578,0000.11%
Weiss Multi-Strategy Advisers LLC 49,000$596,0000.03%
Baker Brothers Advisors 204,465$2,486,0000.02%
View complete list of SYROS PHARMACEUTICALS INC shareholders